Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma
Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma
The objectives are to:

 1. validate a panel of tissue-specific miRNAs that are differentially expressed in the
 tissue of patients with and without reactive hyperplasia and lymphoma.

 2. investigate the physiological range of the miRNA panel in lymphoma and reactive
 hyperplasia subjects.

 3. investigate the dysregulation of miRNA panel and their prognostic and predictive values
 in clinical outcomes to identifying patients with malignant lymphoma or reactive
 hyperplasia.

 The objectives are to:

 1. validate a panel of tissue-specific miRNAs that are differentially expressed in the
 tissue of patients with and without reactive hyperplasia and lymphoma.

 2. investigate the physiological range of the miRNA panel in lymphoma and reactive
 hyperplasia subjects.

 3. investigate the dysregulation of miRNA panel and their prognostic and predictive values
 in clinical outcomes to identifying patients with malignant lymphoma or reactive
 hyperplasia.

 This trial involves tissue samples diagnosed as lymphoma and reactive hyperplasia. The
 investigators will develop panels of miRNAs that are specific biomarkers of lymphoma, and
 assist clinical outcomes with these miRNAs.
Inclusion Criteria:

 -  Adults 18 years and above

 -  Has condition related to lymphoma or reactive lymphoid hyperplasia

 Exclusion Criteria:

 -  Age below 18 years

 -  Known pregnancy

 -  lymph tissue cannot be accessed